A rapid extremely sensitive, quantitative microassay for cytotoxic cytokines

Area of Science:

• Cytokine research
• Cell biology
• Drug-induced sensitivity

Background:

• Cytotoxic cytokines are crucial for immune responses but difficult to study.
• The EMT-6 cell line is typically resistant to cytokine-mediated lysis.
• Accurate assays are needed to characterize cytokine activity.

Purpose of the Study:

• To develop a method for enhancing the sensitivity of EMT-6 cells to cytotoxic cytokines.
• To facilitate the study and purification of cytotoxic cytokines and their associated genetic material.
• To establish a reliable microcytotoxicity assay for cytokine research.

Main Methods:

• Murine mammary adenocarcinoma EMT-6 cells were pretreated with low levels of actinomycin D.
• Cells were subsequently incubated with a range of cytotoxic cytokines.
• Cell viability and lysis were assessed using neutral red uptake and MTT assays.

Main Results:

• Actinomycin D pretreatment converted EMT-6 cells from resistant to highly sensitive to cytotoxic cytokines (5-50 fold increase).
• This drug-induced growth inhibition enabled specific evaluation of cytokine cytolytic effects.
• The assay demonstrated effectiveness compared to the standard actinomycin D-treated L-929 target.

Conclusions:

• Low-dose actinomycin D pretreatment is an effective strategy to sensitize resistant cancer cells to cytotoxic cytokines.
• This approach simplifies the study of cytokine mechanisms and purification processes.
• The developed microcytotoxicity assay is valuable for cytokine research, mRNA purification, and gene expression analysis.